Identifying Pleiotropic SNPs Associated With Femoral Neck and Heel Bone Mineral Density by He, Pei et al.
fgene-11-00772 July 22, 2020 Time: 11:49 # 1
ORIGINAL RESEARCH








The University of Edinburgh,
United Kingdom
Katerina Trajanoska,




†These authors have contributed
equally to this work
Specialty section:
This article was submitted to
Human Genomics,
a section of the journal
Frontiers in Genetics
Received: 12 February 2020
Accepted: 29 June 2020
Published: 22 July 2020
Citation:
He P, Meng X-H, Zhang X, Lin X,
Zhang Q, Jiang R-L, Schiller MR,
Deng F-Y and Deng H-W (2020)
Identifying Pleiotropic SNPs
Associated With Femoral Neck




Associated With Femoral Neck and
Heel Bone Mineral Density
Pei He1,2†, Xiang-He Meng2,3,4†, Xiao Zhang2, Xu Lin2,5, Qiang Zhang2,6, Ri-Li Jiang2,
Martin R. Schiller7, Fei-Yan Deng1 and Hong-Wen Deng2,3,4*
1 Center for Genetic Epidemiology and Genomics, School of Public Health, Medical College of Soochow University, Suzhou,
China, 2 Center for Bioinformatics and Genomics, School of Public Health and Tropical Medicine, Tulane University, New
Orleans, LA, United States, 3 Center of Reproductive Health, System Biology and Data Information, School of Basic Medical
Science, Central South University, Changsha, China, 4 Laboratory of Molecular and Statistical Genetics, College of Life
Sciences, Hunan Normal University, Changsha, China, 5 Department of Endocrinology and Metabolism, The Third Affiliated
Hospital of Southern Medical University, Guangzhou, China, 6 College of Public Health, Zhengzhou University, Zhengzhou,
China, 7 Nevada Institute of Personalized Medicine, School of Life Sciences, University of Nevada, Las Vegas, Las Vegas,
NV, United States
Background: Genome-wide association studies (GWASs) routinely identify loci
associated with risk factors for osteoporosis. However, GWASs with relatively small
sample sizes still lack sufficient power to ascertain the majority of genetic variants with
small to modest effect size, which may together truly influence the phenotype. The loci
identified only account for a small percentage of the heritability of osteoporosis. This
study aims to identify novel genetic loci associated with DXA-derived femoral neck (FNK)
bone mineral density (BMD) and quantitative ultrasound of the heel calcaneus estimated
BMD (eBMD), and to detect shared/causal variants for the two traits, to assess whether
the SNPs or putative causal SNPs associated with eBMD were also associated with
FNK-BMD.
Methods: Novel loci associated with eBMD and FNK-BMD were identified by the
genetic pleiotropic conditional false discovery rate (cFDR) method. Shared putative
causal variants between eBMD and FNK-BMD and putative causal SNPs for each
trait were identified by the colocalization method. Mendelian randomization analysis
addresses the causal relationship between eBMD/FNK-BMD and fracture.
Results: We identified 9,500 (cFDR < 9.8E-6), 137 (cFDR < 8.9E-4) and 124 SNPs
associated with eBMD, FNK-BMD, and both eBMD and FNK-BMD, respectively, with
37 genomic regions where there was a SNP that influences both eBMD and FNK-
BMD. Most genomic regions only contained putative causal SNPs associated with
eBMD and 3 regions contained two distinct putative causal SNPs influenced both traits,
respectively. We demonstrated a causal effect of FNK-BMD/eBMD on fracture.
Conclusion: Most of SNPs or putative causal SNPs associated with FNK-BMD were
also associated with eBMD. However, most of SNPs or putative causal SNPs associated
with eBMD were not associated with FNK-BMD. The novel variants we identified may
help to account for the additional proportion of variance of each trait and advance our
understanding of the genetic mechanisms underlying osteoporotic fracture.
Keywords: osteoporosis, cFDR, colocalization analysis, Mendelian randomization, pleiotropic, causal
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INTRODUCTION
Osteoporosis is a complex disease that prevalently occurs in
postmenopausal women and is diagnosed primarily by measuring
bone mineral density (BMD) (Tella and Gallagher, 2014). Low
femoral neck (FNK) BMD is a major risk factor of osteoporosis
and remains the best predictor of primary osteoporotic fractures
(Meng et al., 2018). It is established that there are differences of
genetic determination among various skeletal sites (Yang et al.,
2006). The heritability of BMD is estimated between 46 and 84%
depending on the skeleton site studied (Mullin et al., 2018).
Although BMD can be measured in many ways, the “gold
standard” diagnostic technique is dual energy absorptiometry
(DXA) of the spine and hip (Tella and Gallagher, 2014). However,
DXA is relatively expensive, and consequently, the genome-wide
association studies (GWASs) of DXA-derived BMD include a
relatively small size of samples, compromising the ability to detect
genetic loci. Quantitative ultrasound (QUS) of the heel calcaneus
estimated BMD (referred to as estimated BMD “eBMD” in this
study) is quick, safe, relatively inexpensive and is cost-effective
for GWASs with very large samples of individuals (Kemp et al.,
2017). The correlations of eBMD with spine (r = 0.50) and hip
BMD (r = 0.54) were modest but stronger in postmenopausal
women (r = 0.60 for spine and r = 0.62 for hip, respectively) (Saadi
et al., 2004). Furthermore, eBMD has been used in combination
with other clinical risk factors to predict the risk of fracture
(Khaw et al., 2004).
Genome-wide association studies is a powerful tool to
identify susceptibility genetic variants of complex diseases. One
previous GWAS identified 56 BMD-associated loci, accounting
for approximately 5.8% of BMD variance (Estrada et al., 2012).
The conditionally independent genome-wide significant lead
single nucleotide polymorphisms (SNPs) account for 20% of the
total variance of eBMD (Morris et al., 2019). However, despite
the relative large sample sizes, GWASs with these sample sizes
may still lack sufficient power to identify the majority of genetic
variants with small to modest effect sizes, which may truly
influence the phenotype (Pei et al., 2014).
Pleiotropy is a phenomenon in which a genetic variant
affects multiple phenotypes. The presence of pleiotropy indicates
that related traits may also share some genetic determinants
(Greenbaum et al., 2017). Identifying potential shared causal
variants among traits can help determine the overlapping
etiologies of multifactorial disorders. Therefore, we considered
variants related to both BMD and normal bone physiology.
There have been limited efforts to ascertain the mechanisms
that alter bone physiology or the causal genes underlying
the GWAS loci (Sabik and Farber, 2017). GWASs allow us
to obtain the estimates of effect size for all those genetic
variants, so it is possible to estimate shared genetic determinants
by checking the correlations between the effect sizes across
traits/bone parameters, which does not need to measure multiple
traits in the same individuals (Bulik-Sullivan et al., 2015). We
used GWAS-derived summary statistics to identify the shared
genetic variants for two related phenotypes with the genetic
pleiotropy-informed conditional false discovery rate (cFDR)
method (Andreassen et al., 2013). This method incorporates the
GWAS-derived summary statistics for two related phenotypes
to test the association of genetic variants with one phenotype
conditional on the different strengths of the association of these
variants with the second phenotype (Greenbaum et al., 2017).
cFDR improves the statistical power and identifies additional
variants associated with each trait and pleiotropic variants from
the studies of traits or diseases (Lv et al., 2017). Bayesian
colocalization models identify genomic regions containing the
same association signal by GWAS and colocalizing expression
quantitative trait loci (eQTL) signals or GWAS signals of two
traits (Giambartolomei et al., 2014; Pickrell et al., 2016). This
model is the basis to integrally consider the effect sizes of all
genetic variants in the pre-defined regions (e.g., approximately
independent linkage disequilibrium (LD) blocks) (Berisa and
Pickrell, 2016) and calculate the posterior probabilities of each
region containing one causal variant associated with both traits
(Giambartolomei et al., 2014; Pickrell et al., 2016).
In this study, we aim to compare those genetic loci associated
with DXA-derived FNK-BMD or eBMD and putative causal
SNPs associated with each trait. Novel variants with pleiotropic
or causal effects on eBMD and FNK-BMD were identified by
cFDR and colocalization analysis of GWAS summary statistics.
Moreover, we investigated the relationship between fracture and
FNK-BMD/eBMD by Mendelian randomization (MR) analysis
of summary statistics in order to assess if FNK-BMD/eBMD
causally underlie fracture risk.
MATERIALS AND METHODS
GWAS Datasets
The summary statistics analyzed were derived from three publicly
available online GWAS datasets: FNK-BMD dataset, eBMD
dataset and fracture dataset. The FNK-BMD GWAS dataset
contained the association results for approximately 10 million
SNPs and is derived from a GWAS meta-analysis of several
studies with 32,965 European subjects published by the Genetic
Factors for Osteoporosis (GEFOS) Consortium (Zheng et al.,
2015). A GWAS meta-analysis was conducted in 426,824 subjects
of European ancestry to study the associations of over 14 million
SNPs with eBMD (Morris et al., 2019). The fracture dataset
was generated from a GWAS meta-analysis of 264,973 European
subjects, containing summary statistics of more than 13 million
SNPs (Morris et al., 2019).
Data Preparation
We pruned SNPs in the FNK-BMD and eBMD datasets before
cFDR analysis using the genotype data from the 1000 Genomes
project as a reference. Briefly, two datasets were combined to
select overlapping SNPs, and then pairs of SNPs with a high
correlation were pruned with a LD-based algorithm (Greenbaum
et al., 2017). Default values of the PLINK 1.9 software (50, 5, 0.2)
were set as parameters when calculating LD values (r2) between
each SNP pair (Greenbaum et al., 2017). The LD was computed
for windows which contained 50 SNPs. The SNP with lower
frequency of the minor allele was excluded for each pair with
r2 > 0.2. The calculation window was then shifted forward by
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5 SNPs. Then repeated above process until each pair of SNPs
were in low LD. Finally, 1,783,638 SNPs were included in the
following analyses.
Data Analysis
Estimating Heritability and Genetic Correlation
Because the previous FNK-BMD GWAS did not show the
proportion of variance explained by the significant findings in
their study, the heritability explained by the previous GWAS
results was estimated using the GWAS summary statistics.
The stratified LD score regression partitioned heritability and
estimated the genetic correlation between FNK-BMD and eBMD
(Finucane et al., 2015).
Conditional FDR Calculation and Conditional
Manhattan Plot
Conditional false discovery rate is an extension of the FDR
method, which combines the GWAS summary statistics of two
phenotypes to evaluate the probability of the association of
genetic variants with the principal phenotype conditioned on the
strength of the association with the conditional phenotype (Liu
et al., 2018). Detailed principles and formulas of the method
were described earlier by Greenbaum (Greenbaum et al., 2017).
P-values from GWAS-derived summary statistics of eBMD and
FNK-BMD were searched to identify common SNPs, through
SNP pruning for cFDR and conjunction cFDR (ccFDR) analyses.
Then we calculated the cFDR for each SNP where FNK-BMD
is the principal phenotype conditioned on the strength of
association with eBMD (FNK-BMD | eBMD) and vice versa
(eBMD | FNK-BMD).
Additionally, ccFDR value was computed to identify
genetic variants associated with both eBMD and FNK-BMD
simultaneously. The ccFDR value is defined as the probability
that the given SNP was wrongly identified to be associated
with both phenotypes. The thresholds of cFDR were set at the
maximum cFDR with p value less than 5 × 10−8 in the principal
phenotype (Liley and Wallace, 2015). Manhattan plots were
created with R software.
Pleiotropic Enrichment Estimation
To assess pleiotropy between eBMD and FNK-BMD, conditional
QQ and fold-enrichment were plotted. We presented the QQ
curves of the quantiles of nominal –log10 (p)-values obtained
from GWAS summary statistics for the association of the SNPs
subsets in the conditional phenotype below each significance
threshold. The x-axis and y-axis are empirical quantiles of the
nominal p values (empirical distribution functions) and nominal
p values (-log10 (p)), respectively. Herein, nominal -log10 (p)-
values were stratified by p-values of conditional phenotype with
the cutoffs as p < 1 (expected base line, all SNPs), p < 0.1,
p < 0.01, p < 0.001 and p < 0.0001. A leftward curve defection
from the expected base line in the QQ plots represents pleiotropic
enrichment shared by two phenotypes.
Nominal p values (- log10 (p)) and fold enrichments were
plotted on the x-axis and the y-axis in fold-enrichment plots,
respectively. We presented fold-enrichment plots of nominal
- log10 (p)-values for eBMD SNPs below the standard GWAS
threshold of p < 5 × 10−8 and for subsets of SNPs determined
by the significance of their association with FNK-BMD and vice
versa. A shift above the expected baseline indicates pleiotropy
between the two phenotypes (Schork et al., 2013).
Colocalization Analysis
The Bayesian colocalization method estimates the probability of
each genomic locus containing a genetic variant that is causally
associated with both traits (Guo et al., 2015). The Bayesian
approach summarizes the evidence of each genetic region for five
mutually exclusive hypotheses simultaneously:
H0: There exists no SNPs in the region that are associated
with either trait,
H1 (Model 1): There exists one causal SNP in the region that
is associated with the first trait,
H2 (Model 2): There exists a causal SNP in the region that
is associated with the second trait,
H3 (Model 3): There exists a single causal SNP in the region
that are associated with both traits,
H4 (Model 4): There exist two distinct causal SNPs in the
region, one for each trait.
Support for each hypothesis is quantified on the basis of
posterior probabilities (PP), defined by PP0, PP1, PP2, PP3, or PP4
(Guo et al., 2015).
Herein, colocalization was analyzed with gwas-pw software
(Pickrell et al., 2016), which is available at https://github.
com/joepickrell/gwas-pw. The method requires the effect size
estimates and standard errors of each SNP for the two
phenotypes. The whole genome was split into 1,703 non-
overlapping regions (blocks). The regional posterior probability
of the region containing one SNP causally associated with both
phenotypes larger than 0.9 corresponded with a FDR < 0.1. The
SNP in each region with the largest posterior probability was
defined as putative causal SNP.
Genes and SNPs Annotation
ANNOVAR software was employed to annotate the SNPs of
interest (Alexander et al., 2017). For genes of interest, Gene
Ontologies (GO) and Kyoto Encyclopedia of Genes and Genomes
(KEEG) pathways were analyzed using DAVID 6.71.
RESULTS
Heritability and Genetic Correlation
The previous FNK-BMD GWAS accounted for 9.1% of the SNP-
based heritability (95% CI: 8.1–10.1%). The genetic correlation
between FNK-BMD and eBMD was estimated to be 0.64
(p = 5.9× 10−61).
1https://david.ncifcrf.gov/summary.jsp
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Pleiotropy Between eBMD and FNK-BMD
The conditional QQ plot for eBMD conditional on FNK-
BMD indicated enrichment of pleiotropic SNPs across the
different significance thresholds for FNK-BMD (Figure 1). An
obvious upward shift from the expected baseline was detected
when restricting the SNPs subgroup with a stronger level
of association with the conditional phenotype, indicating an
increase in the number of true associations for a given FNK-
BMD p-value (Figure 1A). Similar enrichment of pleiotropic
SNPs for FNK-BMD given eBMD, was evidenced by a similar
departure pattern across the different curves (Figure 1B).
For any given eBMD nominal p-value, a deviation from
the null line demonstrated a greater proportion of true
pleiotropic associations.
The fold-enrichment plots showed SNP enrichment for eBMD
with FNK-BMD across different significant levels, and also
for FNK-BMD with eBMD (Figures 1C,D). It illustrated that
between the SNPs subgroup with the strongest association in
the conditional phenotype and all SNPs groups, the proportion
of SNPs associated with the principal phenotype increased by
approximately 30-fold at the genome-wide significance level.
eBMD and FNK-BMD Loci Detected by
cFDR
We identified 9,500 SNPs significantly associated with eBMD
(cFDR < 9.8E-06), given their associations with FNK-BMD
(Supplementary Table S1). All of these SNPs had p values less
than 1 × 10−5 and 8,933 reached the genome-wide significance
at p < 5 × 10−8 in the original GWAS meta-analysis for eBMD
(Kemp et al., 2017). Among the 9,500 SNPs we identified, 50.2%
(4,769 SNPs) were intronic, 1.7% (n = 163) were juxtaposed to the
3’ or 5’ terminals of corresponding genes, and 0.7% (n = 71) were
in the 3’ or 5’ UTR (Supplementary Table S1).
Conditional on the association of SNPs with eBMD, we
identified 137 significant SNPs (cFDR < 8.9E-04) associated with
FNK-BMD (Supplementary Table S2). In the original FNK-
BMD GWAS meta-analysis (Zheng et al., 2015), 7 SNPs had p
values less than 1 × 10−5 while 4 of them reached the standard
genome-wide significance. Among the 137 SNPs identified, 56.2%
(77 SNPs) were intronic, and 1.6% were juxtaposed to the 3’ or 5’
terminals of corresponding genes (Supplementary Table S2).
Pleiotropic SNPs for Both eBMD and
FNK-BMD
We identified 124 pleiotropic SNPs that were significantly
associated with both eBMD and FNK-BMD using ccFDR
method (ccFDR < 8.9E-04) (Supplementary Table S3 and
Figure 2). It suggested that most of SNPs (90.5%, 124137 ) associated
with FNK-BMD were also associated with eBMD. However,
most of SNPs (98.7%, 1- 1249500 ) associated with eBMD were
not associated with FNK-BMD. Although, this can be partly
explained by the relatively large sample size of eBMD study
and the relatively small sample size of FNK-BMD study.
Among these SNPs, 25 previously reached the standard GWAS
significance (p < 5 × 10−8) both in the original eBMD
and FNK-BMD GWASs. Another 95 pleiotropic SNPs were
significantly associated with eBMD in original eBMD GWAS
(original p < 5× 10−8). Four (rs79676715, rs1381635, rs7816021
and rs4263799) of these statistically significant SNPs identified
by ccFDR were not reported by the original eBMD and FNK-
BMD GWASs.
The 124 pleiotropic SNPs were located within 73 different
genes dispersed over 18 autosomes. GO analyses indicated that
these genes were significantly enriched in the canonical Wnt
signaling pathway (GO: 0060070, p = 3.8E-06) and positive
regulation of transcription, DNA-templated (GO: 0045893,
p = 1.3E-05) (Table 1). KEGG pathway analysis confirmed that
pleiotropic genes were significantly enriched in Wnt signaling
pathway (hsa04310, p = 1.8E-06), and also identified signaling
pathways regulating pluripotency of stem cells (hsa04550,
p = 3.9E-05) and genes associated with basal cell carcinoma
(hsa05217, p = 1.5E-05) (Table 2).
Colocalization Analysis
We identified 37 genomic regions containing a SNP
that influences both eBMD and FNK-BMD (model 3)
(Supplementary Table S4), 3 genomic regions containing
two distinct causal SNPs associated with both traits, respectively
(model 4) and 627 regions containing causal SNPs only for
eBMD (model 2) (Supplementary Table S5), at a threshold
of the posterior probability of model 3 larger than 0.9. The 37
putative causal SNPs annotated to 53 different genes, which
were significantly enriched in the biological processes of
canonical Wnt signaling (GO: 0060070, p = 6.5E-07), positive
regulation of transcription (GO: 0045893, p = 6.7E-06), and
DNA-templated and positive regulation of transcription from
RNA polymerase II promoter (GO: 0045944, p = 1.6E-05)
(Table 3). Block 42 (Genomic region: chr1: 66939404–
68477895), containing the candidate gene GNG12-AS1(WLS),
was associated with both eBMD and FNK-BMD, and the
putative casual SNP (rs2566759) in this region is associated
with spine BMD in a previous study (Mullin et al., 2016). Of
the 37 genomic regions identified, 26 contained pleiotropic
SNPs that were identified in ccFDR analysis. We noted
that the putative causal SNPs identified by colocalization
analysis were distinct from pleiotropic SNPs in each genomic
region, suggesting the ccFDR method is apt to identify
the variant associated with both phenotypes instead of the
causal one.
DISCUSSION
In the present study, we combined two GWAS summary statistics
by cFDR to identify the pleiotropic and/or novel SNPs associated
with eBMD and/or FNK-BMD. We discovered 9,500 SNPs and
137 SNPs for eBMD and FNK-BMD, respectively. It suggested
that the majority of SNPs associated with eBMD were not
identified for FNK-BMD. Conjunction cFDR analysis identified
124 pleiotropic SNPs that were significantly associated with both
eBMD and FNK-BMD. We also identified 37 putative causal
SNPs that may underlie both phenotypes using colocalization
analysis. It suggested that both BMD phenotype measurements
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FIGURE 1 | Stratified QQ (A,B) and Enrichment (C,D) plots. Stratified QQ plots of nominal versus empirical –log10 p-values in eBMD as a function of significance of
the association with FNK-BMD (A), and in FNK-BMD as a function of significance of the association with eBMD (B). Fold-enrichment plots (C,D) of enrichment
versus nominal –log10 p-values for eBMD below the standard GWAS threshold of p < 5 × 10−8 as a function of significance of the association with FNK-BMD, and
FNK-BMD below the standard GWAS threshold of p < 5 × 10−8 as a function of significance of the association with eBMD.
shared some causal genetic variants in some regions, but in most
of independent regions (94.5%, 3+62737+3+627 ) the putative causal
SNPs for both phenotypes were different.
As osteoporosis is a complex disease with a strong genetic
component, scientists have strived to identify SNPs associated
with BMD and/or fracture risk. In the present study, we identified
37 candidate SNPs which are causally associated with both eBMD
and FNK-BMD. Among these SNPs, SNP rs884205 is located in
the 3’UTR of tumor necrosis factor (TNF) receptor super family
member 11 a (TNFRSF11A), a gene that is a key driver for BMD
and fracture risk (Tu et al., 2015). TNFRSF11A encodes RANK, a
receptor that regulates bone remodeling. Genetic variation within
the TNFRSF11A gene is associated with BMD in several previous
GWASs (Styrkarsdottir et al., 2009). This SNP is associated with
osteoporotic fractures in a Chinese population (Guo et al., 2012).
Dozens of studies in pre- and postmenopausal women, as well
as in men, reported numerous of genes that are responsible for
regulating serum periostin levels and bone microstructure (Pepe
et al., 2018). These include genes with polymorphisms in low-
density lipoprotein receptor-related protein (LRP5), estrogen-
receptor 1 (ESR1) and tumor necrosis factor receptor super
family member 11 (TNFRSF11) (Pepe et al., 2018). Several novel
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FIGURE 2 | Conjunction Manhattan plot of conjunction –log10 FDR values for
eBMD and FNK-BMD. The red line marking the conditional –log10 ccFDR
value of 3.1 corresponds to a conjunction FDR < 8.9E-04.
putative causal SNPs were near those genes identified in a
previous study, including rs11228240 (LRP5), rs2941741 (ESR1),
and rs78667121 (TNFRSF11).
The SNP rs2566752 is an intronic variant located in the
wntless Wnt ligand secretion mediator (WLS) gene, a known
BMD-associated locus that encodes an integral component of the
Wnt ligand secretion pathway (Mullin et al., 2016). The Wnt
proteins are members of an evolutionarily conserved family of
secreted signaling molecules and are critical for prenatal and
postnatal bone development (de Groot et al., 2014; Zhong et al.,
2015). Variants within the WLS gene are associated with BMD in
several previous GWASs (Rivadeneira et al., 2009). A large meta-
analysis also identified rs2566752 as the maximally associated
variant from the WLS gene region for both lumbar spine and
FNK-BMD (Mullin et al., 2016). Interestingly, bone geometric
parameters and BMD pleiotropy were previously detected at the
WLS locus (Roshandel et al., 2011). These findings suggest that
the associations between rs2566752 and BMD are likely mediated
through regulatory effects on the WLS gene.
Among the 37 putative causal SNPs, five SNPs overlap
with enhancer- or promoter-type chromatin in osteoblasts (i.e.,
rs9594738, rs7587430, rs11023993, rs4776341, and rs71390846)
(Kundaje et al., 2015). Interestingly, rs9594738, overlaps a
weak enhancer-type chromatin, lies ∼54.7 kb downstream
of A-kinase anchor protein 11 (AKAP11) and ∼184.7 kb
upstream of TNFSF11, or commonly known as RANKL. The
role of APAK11 in bone biology is unclear, and it has
broad expression in many types of cell and tissue (Encode
Project Consortium, 2012). However, RANKL is well known
to be involved in RANKL/RANK/osteoprotegerin signaling,
which is one of the key signaling pathways controlling
bone resorption and formation (Chen et al., 2018). In a
recent study, the CRISPR/Cas9 deletion of rs9594738 and
a pleiotropic SNP rs9533090 was shown to reduce RANKL
expression at both mRNA level and protein level in U2-OS cells
(Zhu et al., 2018).
Another putative causal SNP, rs4776341, overlaps with an
active enhancer-type chromatin in osteoblasts, is an intronic
variant located in the sterile alpha motif domain containing 3
(SMAD3) gene, which is part of the important TGF-β1 signaling
pathway for osteoblast and osteoclast differentiation via the
TGF-β1 signaling pathway (Yang et al., 2017). Interestingly,
the SNP rs4776341 is associated with eBMD and FNK-BMD
by the cFDR method. However, in most causal regions, the
putative causal SNPs identified by the colocalization analysis
were different from the pleiotropic SNPs identified by the cFDR
method. This may be because the real causal SNP was removed
using an LD-based pruning method, which was employed to
remove one SNP of pairs with R2 value greater than 0.2 during
the process of data preparation in the cFDR method. For
example, the pleiotropic SNP rs6426749 and putative causal SNP
rs34553872 in block 14 (chr1:21736983-23086441) were in strong
LD (r2 = 1.0). The putative causal SNP rs34553872 was removed
during SNP pruning.
TABLE 1 | GO terms enriched by pleiotropic genes.
Gene Ontology ID: Term Genes p-value FDR
Biological process
GO: 0060070 canonical Wnt signaling pathway WNT4, SMAD3, FZD7, CTNNB1, AXIN1, LRP5 3.78E-06 5.67E-03
GO: 0045893 positive regulation of
transcription, DNA-templated
CRTC3, JAG1, SOX6, GLI3, TCF7L2, ATF1, CTNNB1, FUBP3, DDX17, FLI1,
TNKS, BCAS3, FGF1, BMP2, WNT4, FUBP3, SOST, ESR1, SMAD3, FZD7,
CTNNB1, AXIN1, LRP5, ZNF423
1.29E-05 1.94E-02
TABLE 2 | KEGG pathways enriched by pleiotropic genes.
Term Genes p-value FDR
hsa04310: Wnt signaling pathway WNT16, WNT4, SOST, FZD7, CTNNB1, AXIN1, LRP5 1.80E-06 1.75E-03
hsa05217: Basal cell carcinoma WNT16, WNT4, FZD7, CTNNB1, AXIN1 1.50E-05 1.45E-02
hsa04550: Signaling pathways regulating pluripotency of stem cells WNT16, WNT4, SMAD3, FZD7, CTNNB1, AXIN1 3.94E-05 3.82E-02
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TABLE 3 | GO terms enriched by causal genes.
Gene Ontology ID: Term Genes p-value FDR
Biological process
GO: 0060070 canonical Wnt signaling pathway SMAD3, FZD7, KLF4, CTNNB1, AXIN1, LRP5 6.49E-07 9.35E-04
GO: 0045893 positive regulation of
transcription, DNA-templated
FUBP3, SOST, ESR1, SMAD3, FZD7, KLF4, CTNNB1, AXIN1, LRP5 6.66E-06 9.59E-03
GO: 0045944 positive regulation of
transcription from RNA polymerase II promoter
RPS6KA5, FUBP3, TNFSF11, MEOX1, TRPS1, ESR1, SMAD3, SOX6, KLF4,
CTNNB1, LRP5
1.60E-05 2.30E-02
Investigating a genetic variant influencing multiple
phenotypes is informative in several applications. It can
uncover the shared genetic mechanisms between closely
related phenotypes, as well as the molecular function of a
gene (Solovieff et al., 2013). The cFDR approach was applied
herein to identify pleiotropic genetic variants. This method
is based on the concept that a SNP with a significant effect
on one trait is more likely to be associated with another
correlated trait, and therefore is more likely to be detected by
combining multiple independent studies (Greenbaum et al.,
2017). This approach can not only improve the statistical power
for detecting novel variants with true associations, but can
detect small to intermediate effect sizes (Andreassen et al.,
2013). The genetic enrichment observed in conditional QQ
plots illustrates that the power of detecting true association
effects greatly enhanced as the cFDR value for a given nominal
p value decreased. Andreassen and colleagues showed that
the cFDR method resulted 15–20-fold increase in the number
of SNPs under the same FDR threshold of 0.05, compared
with the traditional unconditional FDR method (Andreassen
et al., 2013). The cFDR method can identify genetic variant
associated with the “principal” phenotype, as long as the
p-value of association with both the “principal” and the
“conditional” phenotypes is below a certain p-value threshold
(Andreassen et al., 2013; Hackinger and Zeggini, 2017). This
method can be used as a variant prioritization tool to identify
other variants associated with one phenotype by utilizing
information of the association with the second phenotype
(Hackinger and Zeggini, 2017). In addition, the cross-phenotype
effect can be detected by calculating the maximum value of
cFDR for two traits.
The colocalization method is based on Z scores of the
SNPs from two input studies, testing an excess of shared
signals, and identifying a set of variants with evidence for
the association with the two traits (Hackinger and Zeggini,
2017). Additionally, we investigated whether causal SNPs are
shared by combining information of multiple SNPs in a
region by a colocalization analysis (Fortune et al., 2015).
The main strength of this method lies in its speed and
analytical forms, and the fact that it can use variants’ effect
size estimates and standard errors when they are the only data
available (Giambartolomei et al., 2014; Pickrell et al., 2016).
This approach focuses on the effects of all SNPs, including
those that do not reach genome-wide significance (Fortune
et al., 2015). Thus, variants of small effect sizes are more
readily identified.
The 124 pleiotropic SNPs identified by the ccFDR analysis
were located in 37 independent blocks which were defined in
colocalization analysis. Among these blocks, 26 overlapped with
causal regions identified by colocalization analysis. This analysis
implies that the cFDR method is more powerful for detecting
pleiotropic SNPs. Although the purpose of colocalization
analysis was to identify the putative causal SNPs affecting
both phenotypes, most of the pleiotropic regions (belonging
to model 3 and model 4) identified by colocalization analysis
contained a putative causal SNP affecting both phenotypes,
rather than two distinct putative causal SNPs in the region
(one for each trait). Both the cFDR and colocalization results
suggest that there is a significant genetic correlation between
the two phenotypes. Consistent with the results of the genetic
correlation analyses, SNPs influencing FNK-BMD were strongly
correlated with eBMD (genetic correlation 0.64, p = 5.92E-
61). The genetic correlation analyses between two traits
indicated that the majority of shared genetic determinants
remains to be discovered. The causal association between
BMD and fracture risk is well established. Herein, we also
found that both FNK-BMD and eBMD have a causal effect
on fracture.
Estimated BMD is derived based on the equation:
0.002592 × (BUA+SOS)-3.687. Previously eBMD study
indicated that eBMD is not an actual measurement of
calcaneal BMD (Frost et al., 2000). Although eBMD is
highly correlated with DXA-derived BMD, there is still
some SNPs which is associated with DXA-derived BMD
but not associated with eBMD. Therefore, we concluded
that eBMD can be a good proxy of BMD but cannot
be a replacement of DXA-derived BMD, especially used
for diagnosis.
We suspected the differences in GWAS sample size
could have had an impact on the cFDR results. Previous
study has performed a large scale GWAS on total body
BMD (TB-BMD) and showed that TB-BMD could be a
good proxy of FNK-BMD. We performed cFDR method
to identify novel variants with pleiotropic effects on
eBMD and TB-BMD using TB-BMD GWAS summary
statistics which comprised over 66,000 individuals (Medina-
Gomez et al., 2018). The results showed that most of
SNPs associated with eBMD were not associated with
TB-BMD. The cFDR results are mainly affected by the
rank of each SNP’s p value, not the exact p value in the
respective GWAS studies of the two traits. Although this
can be partly explained by the different sample sizes of the
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TB-BMD and eBMD datasets, the results should be reasonable
and objective when the studied GWASs datasets are used.
In summary, by applying cFDR and colocalization methods,
we identified pleiotropic SNPs associated with two risk traits
(e.g., eBMD and FNK-BMD) of osteoporotic fracture, and
putative causal SNPs that influence both traits. These findings
suggested that eBMD cannot be used for a replacement of DXA-
derived BMD (e.g., FNK-BMD). These findings may offer novel
pathophysiological insight, and uncover potential targets and
pathways for the trait-associated loci impacting bone health
in osteoporosis.
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